John David Hansen, PRESIDENT AND CEO at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX), sold 1,476 shares at $2.01 ($3K) on 2017-04-07, disclosed to the SEC on 2017-04-11.
Open-market sale of $3k MBVX by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.01 | 666 | $1K | 45.2% |
| 2 | $2.00 | 560 | $1K | 37.9% |
| 3 | $2.00 | 250 | $500 | 16.9% |
| Total | $2.00 avg | 1,476 | $3K | 100% |
| Filing → |
| MBVX | BUY | 2017-08-02 | $8K | — | Filing → |
| MBVX | SELL | 2017-04-14 | $20K | — | Filing → |
| MBVX | SELL | 2017-04-06 | $11K | — | Filing → |